UCB's Global Corporate Website
Welcome to UCB in the United States
PRGLAC_Icon_1280x960

May

16

UCB Participates on NIH Task Force

Last year, the Secretary of Health and Human Services (HHS) appointed UCB’s Kristi Lengyel, Director of U.S. Patient Advocacy, to the National Institutes of Health (NIH) Task Force on Research Specific to Pregnant and Lactating Women (PRGLAC). 

4_5_Untreated

May

07

Disease Spotlight: 5 Things to Know About Osteoporosis

By the time you finish reading the title of this post, a fragility fracture due to osteoporosis has occurred. It is estimated that a fragility fracture occurs every 3 seconds— totaling nearly 9 million fractures annually, worldwide. In the U.S. alone, fragility fractures are responsible for approximately 500,000 hospitalizations, 800,000 emergency room visits, and 180,000 nursing home placements each year.

Canine_Assistants_1280x960

May

02

UCB Engages Community on how Service Dogs Help People with Epilepsy

This spring, UCB engaged the Atlanta community at the 2018 Atlanta Science Festival with a booth called “How the Canine Mind Helps People with Severe Diseases.” The festival is a two-week celebration of science offering more than 100 events at locations throughout metro Atlanta. UCB participated at the expo event held in Piedmont Park on March 24. 

luiz_BTS_1280x960

May

01

UCB’s Dr. Luiz Miguel Camargo, Dedicated to Finding Cures

Luiz Miguel Camargo, Ph.D., UCB’s Director of Innovation Networks, was featured in an interview as part of the Pharmaceutical Research and Manufacturers of America (PhRMA) #GOBOLDLY campaign talking about his work and dedication to advancing science to find solutions. 

Victor_BTS_1280x960

Apr

25

UCB’s Dr. Victor Sloan Shares His Commitment to Go Boldly

Dr. Victor Sloan, UCB’s VP & Development Strategy Lead (immunology), was featured in an interview as part of the Pharmaceutical Research and Manufacturers of America (PhRMA) #GOBOLDLY campaign. Learn more about Dr. Sloan’s work and his motivation to find groundbreaking solutions.

Research_for_blog_post_4.20.18_1280x960

Apr

20

UCB’s Commitment in Neurology

Today, we announced an exciting addition to UCB’s epilepsy pipeline with an agreement to acquire the rights to Proximagen’s Midazolam Nasal Spray (USL261),1 an anti-epilepsy drug (AED) developed as an intended rescue treatment for acute repetitive seizures (ARS, also known as serial, recurrent or cluster seizures) in patients with epilepsy.

bigger-Parkinsons-Stat-with-Logo--source-NEW-WITH-LOGO

Apr

19

UCB Celebrates Parkinson’s Disease Awareness Month

April is Parkinson’s Awareness Month. To honor those living with Parkinson’s disease (PD), we’re spreading awareness about the disease and sharing some of our favorite stories of inspiration.

Blog_Photo_1280x960

Apr

16

Welcome to UCB USA

As the U.S. affiliate of UCB, a global biopharmaceutical company, we are excited to be relaunching UCB-USA.com and a blog with news on UCB in the U.S.

UCB_campus_1280x960

Apr

13

UCBCares is Dedicated to Providing Caring Experiences

UCBCares® is UCB, Inc.'s single source solution center in the U.S. dedicated to providing exceptional caring experiences and solutions for all incoming inquiries to UCB from patients, caregivers, and healthcare providers.

The_Secret_World_Inside_you_1280x960

Mar

06

UCB Sponsors New Exhibit at Atlanta’s Fernbank Museum

UCB is dedicated to supporting STEM education in the communities where we work and live. As part of this commitment, UCB is a proud sponsor of the new special exhibit, “The Secret World Inside You,” at Atlanta’s Fernbank Museum of Natural History.